Sanchez-Paulete, A. (. R., Cueto, F. (. J., Martinez-Lopez, M. (., Labiano-Almiñana, S. (., Morales-Kastresana, A. (., Rodriguez-Ruiz, M. (. E., . . . Melero, I. (. (2016). Cancer immunotherapy with immunomodulatory anti-CD137 and anti-PD-1 monoclonal antibodies requires Batf3-dependent dendritic cells.
Citación estilo ChicagoSanchez-Paulete, A.R. (Alfonso R.)|||/items/b301b8f2-0399-464a-a885-b9b56047cfd7, et al. Cancer Immunotherapy With Immunomodulatory Anti-CD137 and Anti-PD-1 Monoclonal Antibodies Requires Batf3-dependent Dendritic Cells. 2016.
Cita MLASanchez-Paulete, A.R. (Alfonso R.)|||/items/b301b8f2-0399-464a-a885-b9b56047cfd7, et al. Cancer Immunotherapy With Immunomodulatory Anti-CD137 and Anti-PD-1 Monoclonal Antibodies Requires Batf3-dependent Dendritic Cells. 2016.